Clinical Trial Update: Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid Leukemia [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating the dose and safety of Asciminib in pediatric patients with Philadelphia chromosome-positive chronic myeloid leukemia a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Asciminib (asciminib)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Myeloid Leukemia, Philadelphia Positive | Phase 1, Phase 2 | Status: RECRUITING